Caribou Biosciences Stock Market Value
| CRBU Stock | USD 1.98 0.02 1.02% |
| Symbol | Caribou |
Caribou Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caribou Biosciences. If investors know Caribou will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caribou Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Revenue Per Share 0.128 | Quarterly Revenue Growth (0.91) | Return On Assets (0.25) | Return On Equity (0.44) |
The market value of Caribou Biosciences is measured differently than its book value, which is the value of Caribou that is recorded on the company's balance sheet. Investors also form their own opinion of Caribou Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Caribou Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caribou Biosciences' market value can be influenced by many factors that don't directly affect Caribou Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caribou Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Caribou Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caribou Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Caribou Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Caribou Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Caribou Biosciences.
| 05/26/2024 |
| 11/22/2024 |
If you would invest 0.00 in Caribou Biosciences on May 26, 2024 and sell it all today you would earn a total of 0.00 from holding Caribou Biosciences or generate 0.0% return on investment in Caribou Biosciences over 180 days. Caribou Biosciences is related to or competes with Intellia Therapeutics, Editas Medicine, Crispr Therapeutics, Verve Therapeutics, Beam Therapeutics, Fate Therapeutics, and Prime Medicine,. Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allog... More
Caribou Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Caribou Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Caribou Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 28.53 | |||
| Value At Risk | (6.63) | |||
| Potential Upside | 7.42 |
Caribou Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Caribou Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Caribou Biosciences' standard deviation. In reality, there are many statistical measures that can use Caribou Biosciences historical prices to predict the future Caribou Biosciences' volatility.| Risk Adjusted Performance | 0.0073 | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (0.01) |
Caribou Biosciences Backtested Returns
Caribou Biosciences secures Sharpe Ratio (or Efficiency) of -0.0118, which signifies that the company had a -0.0118% return per unit of risk over the last 3 months. Caribou Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Caribou Biosciences' Standard Deviation of 4.89, mean deviation of 3.75, and Risk Adjusted Performance of 0.0073 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 3.31, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Caribou Biosciences will likely underperform. At this point, Caribou Biosciences has a negative expected return of -0.0575%. Please make sure to confirm Caribou Biosciences' total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Caribou Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.01 |
Virtually no predictability
Caribou Biosciences has virtually no predictability. Overlapping area represents the amount of predictability between Caribou Biosciences time series from 26th of May 2024 to 24th of August 2024 and 24th of August 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Caribou Biosciences price movement. The serial correlation of 0.01 indicates that just 1.0% of current Caribou Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.01 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Caribou Biosciences lagged returns against current returns
Autocorrelation, which is Caribou Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Caribou Biosciences' stock expected returns. We can calculate the autocorrelation of Caribou Biosciences returns to help us make a trade decision. For example, suppose you find that Caribou Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Caribou Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Caribou Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Caribou Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Caribou Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Caribou Biosciences Lagged Returns
When evaluating Caribou Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Caribou Biosciences stock have on its future price. Caribou Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Caribou Biosciences autocorrelation shows the relationship between Caribou Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Caribou Biosciences.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Caribou Stock Analysis
When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.